R.A. Wermers, S. Khosla, E.J. Atkinson, S.J. Achenbach, A.L. Oberg, C.S. Grant, L.J. Melton, Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: An update on the changing epidemiology of the disease. J Bone Miner Res 21, 171–177 (2006)

Article  PubMed  Google Scholar 

E.M. Lewiecki, P.D. Miller, Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk. J Clin Densitom 16(1), 28–32 (2013)

Article  PubMed  Google Scholar 

A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E.M. Young, L. Rejnmark, R. Thakker, P. D’Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts, M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28(1), 1–19 (2017)

Article  CAS  PubMed  Google Scholar 

J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts, Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10), 3561–3569 (2014)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Eastell, M.L. Brandi, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10), 3570–3579 (2014)

Article  CAS  PubMed  Google Scholar 

H. Šiprová, Z. Fryšák, M. Souček, Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat? Endocr Pract 22(3), 294–301 (2016)

Article  PubMed  Google Scholar 

K.M. Tordjman, Y. Greenman, E. Osher, G. Shenkerman, N. Stern, Characterization of normocalcemic primary hyperparathyroidism. Am J Med 117(11), 861–863 (2004)

Article  PubMed  Google Scholar 

A.L.P. Lemos, S.R.D.L. Andrade, L.L.H. Pontes, P.M.C. Teixeira, E. Bandeira, L.C. Bandeira, F. Bandeira, High rate of occult urolithiasis in normocalcemic primary hyperparathyroidism. Kidney Blood Press Res 44(5), 1189–1195 (2019)

Article  CAS  PubMed  Google Scholar 

B.R. Hollowoa, H.J. Spencer, B.C. Stack, Normocalcemic and normohormonal primary hyperparathyroidism: laboratory values and end-organ effects. Otolaryngol - Head Neck Surg (United States) 165(3), 387–97 (2021)

Article  Google Scholar 

H.R. Choi, S.H. Choi, N. Hong, Y. Rhee, J.K. Kim, C.R. Lee, S.W. Kang, J. Lee, J.J. Jeong, K.H. Nam, W.Y. Chung, Comparisons between normocalcemic primary hyperparathyroidism and typical primary hyperparathyroidism. J Korean Med Sci 37(13), 1–11 (2022)

Article  Google Scholar 

A. Palermo, R. Jacques, F. Gossiel, D.M. Reid, C. Roux, D. Felsenberg, C.C. Glueer, R. Eastell, Normocalcaemic hypoparathyroidism: Prevalence and effect on bone status in older women. the OPUS study. Clin Endocrinol (Oxf) 82(6), 816–823 (2015)

Article  CAS  PubMed  Google Scholar 

A. García-Martín, R. Reyes-García, M. Muñoz-Torres, Normocalcemic primary hyperparathyroidism: One-year follow-up in one hundred postmenopausal women. Endocrine 42(3), 764–766 (2012)

Article  PubMed  Google Scholar 

M. Boyanov, D. Bakalov, V. Karamfilova, A. Gateva, Y. Assyov, E. Zaharieva, K. Atanassova, G. Sheinkova, A. Tsakova, Z. Kamenov, Primary Hyperparathyroidism – A Contemporary Picture Based on 100 Patients from the Last Decade. acta medica Bulg XLVIII, 5–12 (2021)

Article  Google Scholar 

M. Schini, R.M. Jacques, E. Oakes, N.F. Peel, J.S. Walsh, R. Eastell, Normocalcemic hyperparathyroidism: study of its prevalence and natural history. J Clin Endocrinol Metab 105(4), e1171–e1186 (2020)

Article  PubMed  PubMed Central  Google Scholar 

H. Lowe, D.J. McMahon, M.R. Rubin, J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92(8), 3001–3005 (2007)

Article  CAS  PubMed  Google Scholar 

G. Maruani, A. Hertig, M. Paillard, P. Houillier, Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88(10), 4641–4648 (2003)

Article  CAS  PubMed  Google Scholar 

L.B.C.P. Cavalcante, C.M.Á. Brandão, M.I. Chiamolera, R.P.M. Biscolla, J.V.L. Junior, P. de Sá Tavares Russo, J.P.M. Morgado, C.M.A. de Francischi Ferrer, J.G.H. Vieira, Big data-based parathyroid hormone (PTH) values emphasize need for age correction. J Endocrinol Invest 46(12), 2525–2533 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F. Kamani, A. Najafi, S.S. Mohammadi, S. Tavassoli, S.P. Shojaei, Correlation of biochemical markers of primary hyperparathyroidism with single adenoma weight and volume. Indian J Surg 75(2), 102–105 (2013)

Article  CAS  PubMed  Google Scholar 

B. Filser, V. Uslar, D. Weyhe, N. Tabriz, Predictors of adenoma size and location in primary hyperparathyroidism. Langenbeck’s Arch Surg 406(5), 1607–1614 (2021)

Article  Google Scholar 

S. Stern, A. Mizrachi, Y. Strenov, A. Knaanie, C. Benbassat, T. Shpitzer, G. Bachar, Parathyroid adenoma: a comprehensive biochemical and histological correlative study. Clin Otolaryngol 42(2), 381–386 (2017)

Article  CAS  PubMed  Google Scholar 

J. Costa-Guda, K. Corrado, J. Bellizzi, E. Saria, K. Saucier, M. Guemes-Aragon, G. Kakar, M. Rose, M. Pascal, C. Alander, S.M. Mallya, A. Arnold, Vitamin D deficiency on parathyroid tumorigenesis. Endocrinology 164(11), bqad137 (2023)

Article  PubMed  Google Scholar 

J. Gómez-Ramírez, A. Gómez-Valdazo, P. Luengo, B. Porrero, I. Osorio, S. Rivas, Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form? Am J Surg 219(1), 150–153 (2020)

Article  PubMed  Google Scholar